Skip to main content Accessibility help
×
Home
  • Print publication year: 2019
  • Online publication date: March 2018

11 - Pathology of Malignant Mesothelioma

1.Churg, A, Roggli, V, Chirieac, LR, Galateau-Sallé, F, Burczuk, A, Dacic, S, et al. Sarcomatoid, desmoplastic, and biphasic mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.
2.Galateau-Sallé, F, Churg, A, Roggli, V, Chirieac, LR, Burczuk, A, Cagle, P, et al. Mesothelial tumors. Diffuse malignant mesothelioma. Epithelioid mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.
3.Husain, AN, Colby, T, Ordonez, N, Krausz, T, Attanoos, R, Beasley, MB, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137;647–67.
4.Roggli, V, Borczuk, A, Chirieac, LR, Churg, A, Dacic, S, Galateau-Sallé, F, et al. Sarcomatoid, desmoplastic, and biphasic mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.
5.de Klerk, DP, Nime, F. Adenomatoid tumors (mesothelioma) of testicular and paratesticular tissue. Urology. 1975;6:635–41.
6.Amin, W, Parwani, AV. Adenomatoid tumor of testis. Clin Med Pathol. 2009;2;1722.
7.Gkentzis, A, Sawalem, K, Husain, J. An unusual case of paratesticular mesothelioma on the site of previously excised epididymal adenomatoid tumour. Int J Surg Case Rep. 2013;4:460–62.
8.Hatano, Y, Hirose, Y, Matsunaga, K, Kito, Y, Yasuda, I, Moriwaki, H, et al. Combined adenomatoid tumor and well differentiated papillary mesothelioma of the omentum. Pathol Int. 2011;61:681–85.
9.Makkar, M, Dayal, P, Gupta, C, Mahajan, N. Adenomatoid tumor of testis: a rare cytological diagnosis. J Cytol. 2013;30:6567.
10.Minato, H, Nojima, T, Kurose, N, Kinoshita, E. Adenomatoid tumor of the pleura. Pathol Int. 2009;59:567–71.
11.Bisset, DL, Morris, JA, Fox, H. Giant cystic adenomatoid tumour (mesothelioma) of the uterus. Histopathology. 1988;12:555–58.
12.Chan, JK, Fong, MH. Composite multicystic mesothelioma and adenomatoid tumour of the uterus: different morphological manifestations of the same process? Histopathology. 1996;29:375–77.
13.Katsube, Y, Mukai, K, Silverberg, SG. Cystic mesothelioma of the peritoneum: a report of five cases and review of the literature. Cancer. 1982;50:1615–22.
14.Kawai, T, Kawashima, K, Serizawa, H, Miura, H, Kyeongil, K. Adenomatoid mesothelioma with intranuclear inclusion bodies: a case report with cytological and histological findings. Diagn Cytopathol. 2014;42:436–40.
15.Kurisu, Y, Tsuji, M, Shibayama, Y, Yamada, T, Ohmichi, M. Multicystic mesothelioma caused by endometriosis: 2 case reports and review of the literature. Int J Gynecol Pathol. 2011;30:163–66.
16.Sawada, K, Inoue, K, Ishihara, T, Kurabayashi, A, Moriki, T, Shuin, T. Multicystic malignant mesothelioma of the tunica vaginalis with an unusually indolent clinical course. Hinyokika Kiyo. 2004;50:511–13.
17.Sheng, B, Zhang, YP, Wei, HH, Ma, M, Nan, X. Primary adenomatoid tumor of the testis: report of a case and review of literature. Int J Clin Exp Pathol. 2015;8:5914–18.
18.Terry, NE, Fowler, CL. Benign cystic mesothelioma in a child. J Pediatr Surg. 2009;44:e911.
19.Weiss, SW, Tavassoli, FA. Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases. Am J Surg Pathol. 1988;12:737–46.
20.Chen, X, Sheng, W, Wang, J. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology. 2013;62:805–13.
21.Hanrahan, JB. A combined papillary mesothelioma and adenomatoid tumor of the omentum; report of a case. Cancer. 1963;16:1497–500.
22.Zamecnik, M, Gomolcak, P. Composite multicystic mesothelioma and adenomatoid tumor of the ovary: additional observation suggesting common histogenesis of both lesions. Cesk Patol. 2000;36:160–62.
23.Abratt, RP, White, NW, Vorobiof, DA. Epidemiology of mesothelioma – a South African perspective. Lung Cancer. 2005;49(Suppl 1):S1315.
24.Andersson, M, Olsen, JH. Trend and distribution of mesothelioma in Denmark. Br J Cancer. 1985;51:699705.
25.Armstrong, BK, Musk, AW, Baker, JE, Hunt, JM, Newall, CC, Henzell, HR, et al. Epidemiology of malignant mesothelioma in Western Australia. Med J Aust. 1984;141:8688.
26.Ferguson, DA, Berry, G, Jelihovsky, T, Andreas, SB, Rogers, AJ, Fung, SC, et al. The Australian Mesothelioma Surveillance Program 1979–1985. Med J Aust. 1987;147:166–72.
27.Goldberg, M, Imbernon, E, Rolland, P, Gilg, Soit Ilg A, Saves, M, de Quillacq, A, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006;63:390–95.
28.Hinds, MW. Mesothelioma in the United States. Incidence in the 1970s. J Occup Med. 1978;20:469–71.
29.Leigh, J, Driscoll, T. Malignant mesothelioma in Australia, 1945–2002. Int J Occup Environ Health. 2003;9:206–17.
30.McDonald, AD, McDonald, JC. Malignant mesothelioma in North America. Cancer. 1980;46:1650–56.
31.Peto, J, Decarli, A, La Vecchia, C, Levi, F, Negri, E. The European mesothelioma epidemic. Br J Cancer. 1999;79:666–72.
32.Price, B, Ware, A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Crit Rev Toxicol. 2009;39:576–88.
33.Price, B, Ware, A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159:107–12.
34.Robinson, BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1:491–96.
35.Cao, S, Jin, S, Cao, J, Shen, J, Hu, J, Che, D, et al. Advances in malignant peritoneal mesothelioma. Int J Colorectal Dis. 2015;30:110.
36.Ramachandran, R, Radhan, P, Santosham, R, Rajendiran, S. A rare case of primary malignant pericardial mesothelioma. J Clin Imaging Sci. 2014;4:47.
37.Tateishi, K, Ikeda, M, Yokoyama, T, Urushihata, K, Yamamoto, H, Hanaoka, M, et al. Primary malignant sarcomatoid mesothelioma in the pericardium. Intern Med. 2013;52:249–53.
38.Kayatta, MO, Dineen, SP, Sica, G, Puskas, JD, Pickens, A. Primary pericardial mesothelioma in a 19-year-old presenting as pericarditis. Ann Thorac Surg. 2013;96:680–81.
39.Jiang, D, Kong, M, Li, J, Qian, J. Primary sarcomatoid malignant pericardial mesothelioma. Intern Med. 2013;52:157–58.
40.Godar, M, Liu, J, Zhang, P, Xia, Y, Yuan, Q. Primary pericardial mesothelioma: a rare entity. Case Rep Oncol Med. 2013;2013:283601.
41.Akin, Y, Bassorgun, I, Basara, I, Yucel, S. Malignant mesothelioma of tunica vaginalis: an extremely rare case presenting without risk factors. Singapore Med J. 2015;56:e5355.
42.Yang, LH, Yu, JH, Xu, HT, Lin, XY, Liu, Y, Miao, Y, et al. Mesothelioma of the tunica vaginalis testis with prominent adenomatoid features: a case report. Int J Clin Exp Pathol. 2014;7:7082–87.
43.Rajan, V, Nandhakumar, R, Shanmugasundaram, S, Ravi, R, Natarajan, S, Mohan, G, et al. Paratesticular malignant mesothelioma – a rare case presentation. Indian J Surg. 2013;75:174–76.
44.Yen, CH, Lee, CT, Su, CJ, Lo, HC. Malignant mesothelioma of the tunica vaginalis testis: a malignancy associated with recurrent epididymitis? World J Surg Oncol. 2012;10:238.
45.Mrinakova, B, Ondrus, D, Kajo, K, Kunderlik, M, Tkacova, M, Ondrusova, M. Paratesticular mesothelioma in young age. Case report. Klin Onkol. 2012;25:290–93.
46.Mensi, C, Pellegatta, M, Sieno, C, Consonni, D, Riboldi, L, Bertazzi, PA. Mesothelioma of tunica vaginalis testis and asbestos exposure. BJU Int. 2012;110:533–37.
47.Corfiati, M, Scarselli, A, Binazzi, A, Di Marzio, D, Verardo, M, Mirabelli, D, et al. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer. 2015;15:286.
48.Beckett, P, Edwards, J, Fennell, D, Hubbard, R, Woolhouse, I, Peake, MD. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer. 2015;88:344–48.
49.Kataoka, Y, Yamamoto, Y, Otsuki, T, Shinomiya, M, Terada, T, Fukuma, S, et al. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index. Jpn J Clin Oncol. 2015;45(6):562–68.
50.Meyerhoff, RR, Yang, CF, Speicher, PJ, Gulack, BC, Hartwig, MG, D'Amico, TA, et al. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database. J Surg Res. 2015;196:2332.
51.Najmi, K, Khosravi, A, Seifi, S, Emami, H, Chaibakhsh, S, Radmand, G, et al. Clinicopathologic and survival characteristics of malignant pleural mesothelioma registered in hospital cancer registry. Tanaffos. 2014;13:612.
52.Rolland, P, Gramond, C, Lacourt, A, Astoul, P, Chamming's, S, Ducamp, S, et al. Occupations and industries in France at high risk for pleural mesothelioma: a population-based case-control study (1998–2002). Am J Ind Med. 2010;53:1207–19.
53.McDonald, JC. Epidemiology of malignant mesothelioma – an outline. Ann Occup Hyg. 2010;54:851–57.
54.Teta, MJ, Mink, PJ, Lau, E, Sceurman, BK, Foster, ED. US mesothelioma patterns 1973–2002: indicators of change and insights into background rates. Eur J Cancer Prev. 2008;17:525–34.
55.Gibbs, GW, Berry, G. Mesothelioma and asbestos. Regul Toxicol Pharmacol. 2008;52:S223–31.
56.Robinson, BW, Lake, RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–603.
57.McElvenny, DM, Darnton, AJ, Price, MJ, Hodgson, JT. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond). 2005;55:7987.
58.Hodgson, JT, McElvenny, DM, Darnton, AJ, Price, MJ, Peto, J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005;92:587–93.
59.Musk, AW, de Klerk, NH. Epidemiology of malignant mesothelioma in Australia. Lung Cancer. 2004;45(Suppl 1):S2123.
60.Faig, J, Howard, S, Levine, EA, Casselman, G, Hesdorffer, M, Ohar, JA. Changing pattern in malignant mesothelioma survival. Transl Oncol. 2015;8:3539.
61.Neumann, V, Loseke, S, Nowak, D, Herth, FJ, Tannapfel, A. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int. 2013;110:319–26.
62.Frost, G. The latency period of mesothelioma among a cohort of British asbestos workers (1978–2005). Br J Cancer. 2013;109:1965–73.
63.Bianchi, C, Giarelli, L, Grandi, G, Brollo, A, Ramani, L, Zuch, C. Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev. 1997;6:162–66.
64.Craighead, JE. Epidemiology of mesothelioma and historical background. Recent Results Cancer Res. 2011;189:1325.
65.Berman, DW, Crump, KS. Update of potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol. 2008;38(Suppl 1):147.
66.McDonald, AD, Case, BW, Churg, A, Dufresne, A, Gibbs, GW, Sebastien, P, et al. Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg. 1997;41:707–19.
67.McDonald, JC. Tremolite, other amphiboles, and mesothelioma. Am J Ind Med. 1988;14:247–49.
68.Churg, A. Chrysotile, tremolite, and malignant mesothelioma in man. Chest. 1988;93:621–28.
69.Churg, A. Malignant mesothelioma in British Columbia in 1982. Cancer. 1985;55:672–74.
70.Garabrant, DH, Alexander, DD, Miller, PE, Fryzek, JP, Boffetta, P, Teta, MJ, et al. Mesothelioma among motor vehicle mechanics: an updated review and meta-analysis. Ann Occup Hyg. 2016;60:826.
71.McDonald, JC, McDonald, AD. The epidemiology of mesothelioma in historical context. Eur Respir J. 1996;9:1932–42.
72.Yarborough, CM. The risk of mesothelioma from exposure to chrysotile asbestos. Curr Opin Pulm Med. 2007;13:334–38.
73.Yarborough, CM. Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Crit Rev Toxicol. 2006;36:165–87.
74.Lee, D. Genetic basis of mesothelioma – more than asbestos exposure. J Thorac Oncol. 2016;11:e2728.
75.Ohar, JA, Cheung, M, Talarchek, J, Howard, SE, Howard, TD, Hesdorffer, M, et al. Germline BAP1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer. Cancer Res. 2016;76:206–15.
76.Abakay, A, Tanrikulu, AC, Ayhan, M, Imamoglu, MS, Taylan, M, Kaplan, MA, et al. High-risk mesothelioma relation to meteorological and geological condition and distance from naturally occurring asbestos. Environ Health Prev Med. 2016;21:8290.
77.Chirieac, LR, Barletta, JA, Yeap, BY, Richards, WG, Tilleman, T, Bueno, R, et al. Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol. 2013;31:4544–49.
78.Baumann, F, Buck, BJ, Metcalf, RV, McLaurin, BT, Merkler, DJ, Carbone, M. The presence of asbestos in the natural environment is likely related to mesothelioma in young individuals and women from southern Nevada. J Thorac Oncol. 2015;10:731–37.
79.Demirer, E, Ghattas, CF, Radwan, MO, Elamin, EM. Clinical and prognostic features of erionite-induced malignant mesothelioma. Yonsei Med J. 2015;56:311–23.
80.Kanbay, A, Ozer, Simsek Z, Tutar, N, Yilmaz, I, Buyukoglan, H, Canoz, O, et al. Non-asbestos-related malignant pleural mesothelioma. Intern Med. 2014;53:1977–79.
81.Carbone, M, Baris, YI, Bertino, P, Brass, B, Comertpay, S, Dogan, AU, et al. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci U S A 2011;108:13618–23.
82.Metintas, M, Hillerdal, G, Metintas, S, Dumortier, P. Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors. Arch Environ Occup Health. 2010;65:8693.
83.Dodson, RF, Mark, EJ, Poye, LW. Biodurability/retention of Libby amphiboles in a case of mesothelioma. Ultrastruct Pathol. 2014;38:4551.
84.Jasani, B, Gibbs, A. Mesothelioma not associated with asbestos exposure. Arch Pathol Lab Med. 2012;136:262–67.
85.Dikensoy, O. Mesothelioma due to environmental exposure to erionite in Turkey. Curr Opin Pulm Med. 2008;14:322–25.
86.Carbone, M, Emri, S, Dogan, AU, Steele, I, Tuncer, M, Pass, HI, et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer. 2007;7:147–54.
87.Emri, S, Demir, AU. Malignant pleural mesothelioma in Turkey, 2000–2002. Lung Cancer. 2004;45(Suppl 1):S1720.
88.Farioli, A, Violante, FS, Mattioli, S, Curti, S, Kriebel, D. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control. 2013;24:1535–45.
89.De Bruin, ML, Burgers, JA, Baas, P, van 't Veer, MB, Noordijk, EM, Louwman, MW, et al. Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood. 2009;113:3679–81.
90.Witherby, SM, Butnor, KJ, Grunberg, SM. Malignant mesothelioma following thoracic radiotherapy for lung cancer. Lung Cancer. 2007;57:410–13.
91.Velissaris, TJ, Tang, AT, Millward-Sadler, GH, Morgan, JM, Tsang, GM. Pericardial mesothelioma following mantle field radiotherapy. J Cardiovasc Surg (Torino). 2001;42:425–27.
92.Weissmann, LB, Corson, JM, Neugut, AI, Antman, KH. Malignant mesothelioma following treatment for Hodgkin's disease. J Clin Oncol. 1996;14:2098–100.
93.Cavazza, A, Travis, LB, Travis, WD, Wolfe, JT, Foo, ML, Gillespie, DJ, et al. Post-irradiation malignant mesothelioma. Cancer. 1996;77:1379–85.
94.Comar, M, Zanotta, N, Pesel, G, Visconti, P, Maestri, I, Rinaldi, R, et al. Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy. Tumori. 2012;98:210–14.
95.Price, MJ, Darnton, AJ, McElvenny, DM, Hodgson, JT. Simian virus 40 and mesothelioma in Great Britain. Occup Med (Lond). 2007;57:564–68.
96.De Rienzo, A, Tor, M, Sterman, DH, Aksoy, F, Albelda, SM, Testa, JR. Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem. 2002;84:455–59.
97.Carbone, M, Kratzke, RA, Testa, JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29:217.
98.Carbone, M, Fisher, S, Powers, A, Pass, HI, Rizzo, P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol. 1999;180:167–72.
99.Wolff-Bar, M, Dujovny, T, Vlodavsky, E, Postovsky, S, Morgenstern, SM, Braslavsky, D, et al. An 8-year-old child with malignant deciduoid mesothelioma of the abdomen: report of a case and review of the literature. Pediatr Dev Pathol. 2015;18(4):327–30.
100.Taylor, S, Carpentieri, D, Williams, J, Acosta, J, Southard, R. Malignant peritoneal mesothelioma in an adolescent male with BAP1 deletion. J Pediatr Hematol Oncol. 2015;37(5):e323–27.
101.Kobayashi, S, Waragai, T, Sano, H, Mochizuki, K, Akaihata, M, Ohara, Y, et al. Malignant peritoneal mesothelioma in a child: chemotherapy with gemcitabine and platinum was effective for the disease unresponsive to other treatments. Anticancer Drugs. 2014;25:1102–05.
102.Sugalski, A, Davis, M, Prasannan, L, Saldivar, V, Hung, JY, Tomlinson, GE. Clinical, histologic, and genetic features of mesothelioma in a 7-year-old child. Pediatr Blood Cancer. 2013;60:146–48.
103.Rosas-Salazar, C, Gunawardena, SW, Spahr, JE. Malignant pleural mesothelioma in a child with ataxia–telangiectasia. Pediatr Pulmonol. 2013;48:9497.
104.Khan, MA, Puri, P, Devaney, D. Mesothelioma of tunica vaginalis testis in a child. J Urol. 1997;158:198–99.
105.Fraire, AE, Cooper, S, Greenberg, SD, Buffler, P, Langston, C. Mesothelioma of childhood. Cancer. 1988;62:838–47.
106.Armstrong, GR, Raafat, F, Ingram, L, Mann, JR. Malignant peritoneal mesothelioma in childhood. Arch Pathol Lab Med. 1988;112:1159–62.
107.Berry, PJ, Favara, BE, Odom, LF. Malignant peritoneal mesothelioma in a child. Pediatr Pathol. 1986;5:397409.
108.Kovalivker, M, Motovic, A. Malignant peritoneal mesothelioma in children: description of two cases and review of the literature. J Pediatr Surg. 1985;20:274–75.
109.Wassermann, M, Wassermann, D, Steinitz, R, Katz, L, Lemesch, C. Mesothelioma in children. IARC Sci Publ. 1980;30:253–57.
110.Kauffman, SL, Stout, AP. Mesothelioma in children. Cancer. 1964;17:539–44.
111.Ascoli, V, Romeo, E, Carnovale, Scalzo C, Cozzi, I, Ancona, L, Cavariani, F, et al. Familial malignant mesothelioma: a population-based study in central Italy (1980–2012). Cancer Epidemiol. 2014;38:273–78.
112.Kalogeraki, AM, Tamiolakis, DJ, Lagoudaki, ED, Papadakis, MN, Papadakis, GZ, Agelaki, SI, et al. Familial mesothelioma in first degree relatives. Diagn Cytopathol. 2013;41:654–57.
113.Serio, G, Scattone, A, Gentile, M, Nazzaro, P, Pennella, A, Buonadonna, AL, et al. Familial pleural mesothelioma with environmental asbestos exposure: losses of DNA sequences by comparative genomic hybridization (CGH). Histopathology. 2004;45:643–45.
114.Musti, M, Cavone, D, Aalto, Y, Scattone, A, Serio, G, Knuutila, S. A cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly. Cancer Genet Cytogenet. 2002;138:7376.
115.Saracci, R, Simonato, L. Familial malignant mesothelioma. Lancet. 2001;358:1813–14.
116.Ascoli, V, Scalzo, CC, Bruno, C, Facciolo, F, Lopergolo, M, Granone, P, et al. Familial pleural malignant mesothelioma: clustering in three sisters and one cousin. Cancer Lett. 1998;130:203–07.
117.Risberg, B, Nickels, J, Wagermark, J. Familial clustering of malignant mesothelioma. Cancer. 1980;45:2422–27.
118.Baumann, F, Flores, E, Napolitano, A, Kanodia, S, Taioli, E, Pass, H, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36:7681.
119.Betti, M, Casalone, E, Ferrante, D, Romanelli, A, Grosso, F, Guarrera, S, et al. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area. Genes Chromosomes Cancer. 2015;54:5162.
120.Xu, J, Kadariya, Y, Cheung, M, Pei, J, Talarchek, J, Sementino, E, et al. Germline mutation of BAP1 accelerates development of asbestos-induced malignant mesothelioma. Cancer Res. 2014;74:4388–97.
121.Ribeiro, C, Campelos, S, Moura, CS, Machado, JC, Justino, A, Parente, B. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol. 2013;24:2147–50.
122.Carbone, M, Ferris, LK, Baumann, F, Napolitano, A, Lum, CA, Flores, EG, et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012;10:179.
123.Testa, JR, Cheung, M, Pei, J, Below, JE, Tan, Y, Sementino, E, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43:1022–25.
124.Rusch, A, Ziltener, G, Nackaerts, K, Weder, W, Stahel, RA, Felley-Bosco, E. Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung Cancer. 2015;87:7779.
125.Cheung, M, Talarchek, J, Schindeler, K, Saraiva, E, Penney, LS, Ludman, M, et al. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genet. 2013;206:206–10.
126.Marchevsky, AM, Harber, P, Crawford, L, Wick, MR. Mesothelioma in patients with nonoccupational asbestos exposure. An evidence-based approach to causation assessment. Ann Diagn Pathol. 2006;10:241–50.
127.Robinson, BW, Musk, AW, Lake, RA. Malignant mesothelioma. Lancet. 2005;366:397408.
128.Choi, BY, Yoon, MJ, Shin, K, Lee, YJ, Song, YW. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus. 2015;24:321–26.
129.Dogan, M, Utkan, G, Hocazade, C, Uncu, D, Toptas, S, Ozdemir, N, et al. The clinicopathological characteristics with long-term outcomes in malignant mesothelioma. Med Oncol. 2014;31:232.
130.Mott, FE. Mesothelioma: a review. Ochsner J. 2012;12:7079.
131.Haber, SE, Haber, JM. Malignant mesothelioma: a clinical study of 238 cases. Ind Health. 2011;49:166–72.
132.Gill, RR. Imaging of mesothelioma. Recent Results Cancer Res. 2011;189:2743.
133.Marrannes, J, Delvaux, S, Verheezen, J. Malignant peritoneal mesothelioma: contribution and limitation of imaging for its diagnosis. JBR-BTR. 2009;92:248–50.
134.Smith, TR. Malignant peritoneal mesothelioma: marked variability of CT findings. Abdom Imaging. 1994;19:2729.
135.Bianchi, C, Brollo, A, Ramani, L, Zuch, C. Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study. Am J Ind Med. 1997;32:445–49.
136.Hillerdal, G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. A prospective study. Chest. 1994;105:144–50.
137.Borasio, P, Berruti, A, Bille, A, Lausi, P, Levra, MG, Giardino, R, et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg. 2008;33:307–13.
138.Nickell, LT., Lichtenberger, JP, 3rd, Khorashadi, L, Abbott, GF, Carter, BW. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics. 2014;34:1692–706.
139.Truong, MT, Viswanathan, C, Godoy, MB, Carter, BW, Marom, EM. Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations. Semin Roentgenol. 2013;48:323–34.
140.Larsen, BT, Klein, JR, Hornychova, H, Nuti, R, Thirumala, S, Leslie, KO, et al. Diffuse intrapulmonary malignant mesothelioma masquerading as interstitial lung disease: a distinctive variant of mesothelioma. Am J Surg Pathol. 2013;37:1555–64.
141.Amosite asbestos and mesothelioma. Lancet 1981;2:1397–98.
142.Boffetta, P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985–90.
143.Suster, S, Moran, CA. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol. 2006;13:316–29.
144.Hjerpe, A, Ascoli, V, Bedrossian, CW, Boon, ME, Creaney, J, Davidson, B, et al. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Acta Cytol. 2015;59:216.
145.Kawai, T, Hiroshima, K, Kamei, T. Pulmonary Pathology: SY22–2 diagnosis of mesothelioma by cytology using Japanese criteria. Pathology. 2014;46(Suppl 2):S39.
146.Segal, A, Sterrett, GF, Frost, FA, Shilkin, KB, Olsen, NJ, Musk, AW, et al. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit. Pathology. 2013;45:4448.
147.Paintal, A, Raparia, K, Zakowski, MF, Nayar, R. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey. Cancer Cytopathol. 2013;121:703–07.
148.Arrossi, AV, Lin, E, Rice, D, Moran, CA. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. Am J Clin Pathol. 2008;130:754–64.
149.Burkholder, D, Hadi, D, Kunnavakkam, R, Kindler, H, Todd, K, Celauro, AD, et al. Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma. Ann Thorac Surg. 2015;99:1775–80.
150.Cao, C, Tian, D, Park, J, Allan, J, Pataky, KA, Yan, TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83:240–45.
151.Cardillo, G, Treasure, T. Extrapleural pneumonectomy is not shown to be clinically effective in the treatment of malignant pleural mesothelioma. Ann Surg. 2017;265(4):e53.
152.Chirieac, LR, Pinkus, GS, Pinkus, JL, Godleski, J, Sugarbaker, DJ, Corson, JM. The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura. Am J Cancer Res. 2011;1:1424.
153.de Perrot, M, McRae, K, Anraku, M, Karkouti, K, Waddell, TK, Pierre, AF, et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg. 2008;85:1206–10.
154.Gupta, V, Krug, LM, Laser, B, Hudka, K, Flores, R, Rusch, VW, et al. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy. J Thorac Oncol. 2009;4:746–50.
155.Sugarbaker, DJ, Wolf, AS, Chirieac, LR, Godleski, JJ, Tilleman, TR, Jaklitsch, MT, et al. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg. 2011;40:298303.
156.Taioli, E, Wolf, AS, Flores, RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99:472–80.
157.Ito, T, Hamasaki, M, Matsumoto, S, Hiroshima, K, Tsujimura, T, Kawai, T, et al. p16/CDKN2A FISH in differentiation of diffuse malignant peritoneal mesothelioma from mesothelial hyperplasia and epithelial ovarian cancer. Am J Clin Pathol. 2015;143:830–38.
158.Hasegawa, M, Sakai, F, Sato, A, Tsubomizu, S, Arimura, K, Katsura, H, et al. FISH analysis of intrapulmonary malignant mesothelioma without a clinically detectable primary pleural lesion: an autopsy case. Jpn J Clin Oncol. 2014;44:1239–42.
159.Hwang, H, Tse, C, Rodriguez, S, Gown, A, Churg, A. p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma. Am J Surg Pathol. 2014;38:681–88.
160.Wu, D, Hiroshima, K, Matsumoto, S, Nabeshima, K, Yusa, T, Ozaki, D, et al. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis. Am J Clin Pathol. 2013;139:3946.
161.Matsumoto, S, Nabeshima, K, Kamei, T, Hiroshima, K, Kawahara, K, Hata, S, et al. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology. Cancer Cytopathol. 2013;121:415–22.
162.Al-Salam, S, Hammad, FT, Salman, MA, AlAshari, M. Expression of Wilms tumor-1 protein and CD 138 in malignant mesothelioma of the tunica vaginalis. Pathol Res Pract. 2009;205:797800.
163.Illei, PB, Ladanyi, M, Rusch, VW, Zakowski, MF. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer. 2003;99:5156.
164.Cheng, JQ, Jhanwar, SC, Klein, WM, Bell, DW, Lee, WC, Altomare, DA, et al. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res. 1994;54:5547–51.
165.Hiroshima, K, Wu, D, Hasegawa, M, Koh, E, Sekine, Y, Ozaki, D, et al. Cytologic differential diagnosis of malignant mesothelioma and reactive mesothelial cells with FISH analysis of p16. Diagn Cytopathol. 2016;44(7):591–98.
166.Cigognetti, M, Lonardi, S, Fisogni, S, Balzarini, P, Pellegrini, V, Tironi, A, et al. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol. 2015;28:1043–57.
167.Walts, AE, Hiroshima, K, McGregor, SM, Wu, D, Husain, AN, Marchevsky, AM. BAP1 immunostain and CDKN2A (p16) FISH analysis: clinical applicability for the diagnosis of malignant mesothelioma in effusions. Diagn Cytopathol. 2016;44(7):599606.
168.Roggli, V, Churg, A, Chirieac, LR, Burczuk, A, Dacic, S, Hammar, S, et al. Sarcomatoid, desmoplastic, and biphasic mesothelioma. In: Travis, WD, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.
169.Travis, LB, Brambilla, E, Burke, AP, Marx, A, Nicholson, AG, editors. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press, 2015.
170.Oury, TD, Sporn, TA, Roggli, VL. Pathology of asbestos-associated diseases. New York, NY: Springer, 2014.
171.Makarawate, P, Chaosuwannakit, N, Chindaprasirt, J, Ungarreevittaya, P, Chaiwiriyakul, S, Wirasorn, K, et al. Malignant mesothelioma of the pericardium: a report of two different presentations. Case Rep Oncol Med. 2013;2013:356901.
172.Churg, A, Cagle, PT, Roggli, V. Tumors of the serosal membranes. Washington, DC: American Registry of Pathology, 2006.
173.Brcic, L, Jakopovic, M, Brcic, I, Klaric, V, Milosevic, M, Sepac, A, et al. Reproducibility of histological subtyping of malignant pleural mesothelioma. Virchows Arch. 2014;465:679–85.
174.Mogi, A, Nabeshima, K, Hamasaki, M, Uesugi, N, Tamura, K, Iwasaki, A, et al. Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis. Pathol Int. 2009;59:874–79.
175.Mark, EJ, Shin, DH. Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Arch A Pathol Anat Histopathol. 1993;422:445–51.
176.Weissferdt, A, Kalhor, N, Suster, S. Malignant mesothelioma with prominent adenomatoid features: a clinicopathologic and immunohistochemical study of 10 cases. Ann Diagn Pathol. 2011;15:2529.
177.Ordonez, NG, Myhre, M, Mackay, B. Clear cell mesothelioma. Ultrastruct Pathol. 1996;20:331–36.
178.Ordonez, NG, Mackay, B. Glycogen-rich mesothelioma. Ultrastruct Pathol. 1999;23:401–06.
179.Ordonez, NG. Mesothelioma with clear cell features: an ultrastructural and immunohistochemical study of 20 cases. Hum Pathol. 2005;36:465–73.
180.Ustun, H, Astarci, HM, Sungu, N, Ozdemir, A, Ekinci, C. Primary malignant deciduoid peritoneal mesothelioma: a report of the cytohistological and immunohistochemical appearances. Diagn Cytopathol. 2011;39:402–08.
181.Tsai, LY, Yang, YL, Lu, MY, Lin, DT, Huang, HY, Lin, KH. Deciduoid mesothelioma of the pleura in an adolescent boy. Pediatr Hematol Oncol. 2010;27:132–37.
182.Talerman, A. Deciduoid or pseudodecidual mesothelioma. Am J Surg Pathol. 2000;24:1179.
183.Shia, J, Erlandson, RA, Klimstra, DS. Deciduoid mesothelioma: a report of 5 cases and literature review. Ultrastruct Pathol. 2002;26:355–63.
184.Serio, G, Scattone, A, Pennella, A, Giardina, C, Musti, M, Valente, T, et al. Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival. Histopathology. 2002;40:348–52.
185.Santos, C, Gamboa, F, Fradinho, F, Pego, A, Carvalho, L, Bernardo, J. Deciduoid pleural mesothelioma–a rare entity in a young woman. Rev Port Pneumol. 2012;18:294–98.
186.Puttagunta, L, Vriend, RA, Nguyen, GK. Deciduoid epithelial mesothelioma of the pleura with focal rhabdoid change. Am J Surg Pathol. 2000;24:1440–43.
187.Orosz, Z, Nagy, P, Szentirmay, Z, Zalatnai, A, Hauser, P. Epithelial mesothelioma with deciduoid features. Virchows Arch. 1999;434:263–66.
188.Ordonez, NG. Deciduoid mesothelioma: report of 21 cases with review of the literature. Mod Pathol. 2012;25:1481–95.
189.Nascimento, AG, Keeney, GL, Fletcher, CD. Deciduoid peritoneal mesothelioma. An unusual phenotype affecting young females. Am J Surg Pathol. 1994;18:439–45.
190.Ordonez, NG. Epithelial mesothelioma with deciduoid features: report of four cases. Am J Surg Pathol. 2000;24:816–23.
191.Gloeckner-Hofmann, K, Zhu, XZ, Bartels, H, Feller, AC, Merz, H. Deciduoid pleural mesothelioma affecting a young female without prior asbestos exposure. Respiration. 2000;67:456–58.
192.Desai, S, Kane, S, Bharde, S, Kulkarni, JN, Soman, CS. Malignant peritoneal mesothelioma deciduoid or anaplastic variant? A point to ponder. Indian J Pathol Microbiol. 2000;43:479–83.
193.Okonkwo, A, Musunuri, S, Diaz, L., Bedrossian, C, Stryker, S, Rao, S. Deciduoid mesothelioma: a rare, distinct entity with unusual features. Ann Diagn Pathol. 2001;5:168–71.
194.Monaghan, H, Al-Nafussi, A. Deciduoid pleural mesothelioma. Histopathology. 2001;39:104–06.
195.Henley, JD, Loehrer, PJ., Ulbright, TM. Deciduoid mesothelioma of the pleura after radiation therapy for Hodgkin's disease presenting as a mediastinal mass. Am J Surg Pathol. 2001;25:547–48.
196.Gillespie, FR, van der Walt, JD, Derias, N, Kenney, A. Deciduoid peritoneal mesothelioma. A report of the cytological appearances. Cytopathology. 2001;12:5761.
197.Desai, S, Kane, S, Bharde, S, Kulkarni, JN, Soman, CS. Malignant peritoneal mesothelioma deciduoid or anaplastic variant? Point to ponder. Indian J Pathol Microbiol. 2001;44:159–62.
198.Cook, HC. Small cell mesothelioma. Histopathology. 1993;22:294–95.
199.Tsao, AS, Heymach, J. Mesothelioma and small cell lung cancer. J Thorac Oncol. 2011;6:S1825–26.
200.Takeda, T, Saitoh, M, Fukita, S, Takeda, S. Small cell carcinoma presenting with massive pleural spread mimicking malignant pleural mesothelioma. Intern Med. 2014;53:613–16.
201.Allen, TC. Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies. Arch Pathol Lab Med. 2005;129:1415–20.
202.Cook, DS, Attanoos, RL, Jalloh, SS, Gibbs, AR. ‘Mucin-positive’ epithelial mesothelioma of the peritoneum: an unusual diagnostic pitfall. Histopathology. 2000;37:3336.
203.Ohnuma-Koyama, A, Yoshida, T, Takahashi, N, Akema, S, Takeuchi-Kashimoto, Y, Kuwahara, M, et al. Malignant peritoneal mesothelioma with a sarcomatoid growth pattern and signet-ring-like structure in a female f344 rat. J Toxicol Pathol. 2013;26:197201.
204.Ordonez, NG. Mesothelioma with signet-ring cell features: report of 23 cases. Mod Pathol. 2013;26:370–84.
205.Rekhi, B, Pathuthara, S, Ajit, D, Kane, SV. “Signet-ring” cells – a caveat in the diagnosis of a diffuse peritoneal mesothelioma occurring in a lady presenting with recurrent ascites: an unusual case report. Diagn Cytopathol. 2010;38:435–39.
206.Matsukuma, S, Aida, S, Hata, Y, Sugiura, Y, Tamai, S. Localized malignant peritoneal mesothelioma containing rhabdoid cells. Pathol Int. 1996;46:389–91.
207.Ordonez, NG. Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases. Mod Pathol. 2006;19:373–83.
208.Ordonez, NG. Pleomorphic mesothelioma: report of 10 cases. Mod Pathol. 2012;25:1011–22.
209.Kadota, K, Suzuki, K, Sima, CS, Rusch, VW, Adusumilli, PS, Travis, WD. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma. J Thorac Oncol. 2011;6:896904.
210.Husain, AN, Colby, TV, Ordonez, NG, Krausz, T, Borczuk, A, Cagle, PT, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009;133:1317–31.
211.Marchevsky, AM. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med. 2008;132:397401.
212.Marchevsky, AM, Wick, MR. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol. 2007;15:140–44.
213.Yaziji, H, Battifora, H, Barry, TS, Hwang, HC, Bacchi, CE, McIntosh, MW, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol. 2006;19:514–23.
214.Battifora, H, Kopinski, MI. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer. 1985;55:1679–85.
215.Ordonez, NG. Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update. Hum Pathol. 2013;44:119.
216.Jo, VY, Cibas, ES, Pinkus, GS. Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology. Cancer Cytopathol. 2014;122:299306.
217.Ordonez, NG. Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma. Mod Pathol. 2013;26:1132–43.
218.Ordonez, NG. Value of claudin-4 immunostaining in the diagnosis of mesothelioma. Am J Clin Pathol. 2013;139:611–19.
219.Ohta, Y, Sasaki, Y, Saito, M, Kushima, M, Takimoto, M, Shiokawa, A, et al. Claudin-4 as a marker for distinguishing malignant mesothelioma from lung carcinoma and serous adenocarcinoma. Int J Surg Pathol. 2013;21:493501.
220.Facchetti, F, Lonardi, S, Gentili, F, Bercich, L, Falchetti, M, Tardanico, R, et al. Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions. Virchows Arch. 2007;451:669–80.
221.Facchetti, F, Gentili, F, Lonardi, S, Bercich, L, Santin, A. Claudin-4 in mesothelioma diagnosis. Histopathology. 2007;51:261–63.
222.Soini, Y, Kinnula, V, Kahlos, K, Paakko, P. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol. 2006;59:250–54.
223.Kimura, T, Doi, Y, Nakashima, T, Imano, N, Katsuta, T, Takahashi, S, et al. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy. J Radiat Res. 2015;56:315–24.
224.Tsukamoto, Y, Hao, H, Kajimoto, N, Katayama, A, Suzuki, C, Terada, T, et al. Sarcomatoid pleural mesothelioma with osteosarcomatous, chondrosarcomatous and rhabdomyoblastic elements: an extremely rare autopsy case. Pathol Int. 2015;65:5153.
225.Liu, S, Staats, P, Lee, M, Alexander, HR, Burke, AP. Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients. Pathology. 2014;46:604–09.
226.Lee, M, Alexander, HR, Burke, A. Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy. Pathology. 2013;45:464–73.
227.Henderson, DW, Reid, G, Kao, SC, van Zandwijk, N, Klebe, S. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA. J Clin Pathol. 2013;66:854–61.
228.Nakamura, M, Kobashikawa, K, Uchima, N, Hirata, T. Sarcomatoid peritoneal malignant mesothelioma. Intern Med. 2011;50:2045.
229.Klebe, S, Brownlee, NA, Mahar, A, Burchette, JL, Sporn, TA, Vollmer, RT, et al. Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases. Mod Pathol. 2010;23:470–79.
230.Salgado, RA, Corthouts, R, Parizel, PM, Germonpre, P, Carp, L, Van Schil, P, et al. Malignant pleural mesothelioma with heterologous osteoblastic elements: computed tomography, magnetic resonance, and positron emission tomography imaging characteristics of a rare tumor. J Comput Assist Tomogr. 2005;29:653–56.
231.Chave, G, Chalabreysse, L, Picaud, G, Blineau, N, Loire, R, Thivolet, F, et al. Malignant pleural mesothelioma with osteoblastic heterologous elements: CT and MR imaging findings. AJR Am J Roentgenol. 2002;178:949–51.
232.Badak, B, Turk, O, Ates, E, Arik, D. Desmoplastic malignant mesothelioma of the peritoneum. Oxf Med Case Reports. 2014;2014:4951.
233.Horiuchi, T, Ogata, S, Tominaga, S, Hiroi, S, Kawahara, K, Hebisawa, A, et al. Immunohistochemistry of cytokeratins 7, 8, 17, 18, and 19, and GLUT-1 aids differentiation of desmoplastic malignant mesothelioma from fibrous pleuritis. Histol Histopathol. 2013;28:663–70.
234.Baccioglu, A, Kaba, E, Ozmen, SA, Demirci, M. Desmoplastic malignant mesothelioma. J Bronchology Interv Pulmonol. 2013;20:155–58.
235.Takamaru, H, Arimura, Y, Shinomura, Y. Desmoplastic malignant mesothelioma originating from the peritoneum. Med Oncol. 2012;29:3155–56.
236.Ishikawa, R, Kikuchi, E, Jin, M, Fujita, M, Itoh, T, Sawa, H, et al. Desmoplastic malignant mesothelioma of the pleura: autopsy reveals asbestos exposure. Pathol Int. 2003;53:401–06.
237.Hirano, H, Maeda, H, Sawabata, N, Okumura, Y, Takeda, S, Maekura, R, et al. Desmoplastic malignant mesothelioma: two cases and a literature review. Med Electron Microsc. 2003;36:173–78.
238.Colby, TV. The diagnosis of desmoplastic malignant mesothelioma. Am J Clin Pathol. 1998;110:135–36.
239.Thomas, JS, Burnett, RA. Desmoplastic mesothelioma. Thorax. 1988;43:584.
240.Cantin, R, Al-Jabi, M, McCaughey, WT. Desmoplastic diffuse mesothelioma. Am J Surg Pathol. 1982;6:215–22.
241.Yamamoto, J, Ueta, K, Takenaka, M, Takahashi, M, Nishizawa, S. Sarcomatoid malignant mesothelioma presenting with intramedullary spinal cord metastasis: a case report and literature review. Global Spine J. 2014;4:115–20.
242.Goldova, B, Dundr, P, Zikan, M, Tomancova, V. Myxoid variant of peritoneal epithelioid malignant mesothelioma. A case report. Cesk Patol. 2014;50:149–51.
243.Yang, GZ, Li, J, Ding, HY. Localized malignant myxoid anaplastic mesothelioma of the pericardium. J Clin Med Res. 2009;1:115–18.
244.Minato, H, Kurose, N, Fukushima, M, Nojima, T, Usuda, K, Sagawa, M, et al. Comparative immunohistochemical analysis of IMP3, GLUT1, EMA, CD146, and desmin for distinguishing malignant mesothelioma from reactive mesothelial cells. Am J Clin Pathol. 2014;141:8593.
245.Hyun, TS, Barnes, M, Tabatabai, ZL. The diagnostic utility of D2–40, calretinin, CK5/6, desmin and MOC-31 in the differentiation of mesothelioma from adenocarcinoma in pleural effusion cytology. Acta Cytol. 2012;56:527–32.
246.Hasteh, F, Lin, GY, Weidner, N, Michael, CW. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118:9096.
247.Geyer, SJ. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol. 2010;118:225; author reply 225.
248.Takeshima, Y, Amatya, VJ, Kushitani, K, Kaneko, M, Inai, K. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Histopathology. 2009;54:667–76.
249.Salman, WD, Eyden, B, Shelton, D, Howat, A, Al-Dawoud, A, Twaij, Z. An EMA negative, desmin positive malignant mesothelioma: limitations of immunohistochemistry? J Clin Pathol. 2009;62:651–52.
250.Comin, CE, Dini, S, Novelli, L, Santi, R, Asirelli, G, Messerini, L. h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type. Am J Surg Pathol. 2006;30:463–69.
251.Comin, CE, Saieva, C, Messerini, L. h-Caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary. Am J Surg Pathol. 2007;31:1139–48.
252.Shi, M, Fraire, AE, Chu, P, Cornejo, K, Woda, BA, Dresser, K, et al. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation. Am J Surg Pathol. 2011;35:878–82.
253.Laury, AR, Hornick, JL, Perets, R, Krane, JF, Corson, J, Drapkin, R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010;34:627–35.
254.Butnor, KJ, Sporn, TA, Ordonez, NG, Association of Directors of Anatomic and Surgical Pathology (ADASP). Recommendations for the reporting of pleural mesothelioma. Hum Pathol. 2007;38:1587–89.
255.Davidson, B. Prognostic factors in malignant pleural mesothelioma. Hum Pathol. 2015;46:789804.
256.Scherpereel, A, Astoul, P, Baas, P, Berghmans, T, Clayson, H, de Vuyst, P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479–95.
257.Chirieac, LR, Corson, JM. Pathologic evaluation of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21:121–24.
258.Kadota, K, Suzuki, K, Colovos, C, Sima, CS, Rusch, VW, Travis, WD, et al. A nuclear grading system is a strong predictor of survival in epithelioid diffuse malignant pleural mesothelioma. Mod Pathol. 2012;25:260–71.
259.Yang, GC. Long microvilli of mesothelioma are conspicuous in pleural effusions processed by Ultrafast Papanicolaou stain. Cancer. 2003;99:1722.
260.Zu, Y, Sidhu, GS, Wieczorek, R, Cassai, ND. Ultrastructurally “invasive” microvilli in an aggressively metastasizing biphasic malignant mesothelioma. Ultrastruct Pathol. 2002;26:403–09.
261.Coleman, M, Henderson, DW, Mukherjee, TM. The ultrastructural pathology of malignant pleural mesothelioma. Pathol Annu. 1989;24(Pt 1):303–53.
262.Oczypok, EA, Oury, TD. Electron microscopy remains the gold standard for the diagnosis of epithelial malignant mesothelioma: a case study. Ultrastruct Pathol. 2015;39:153–58.
263.Suzuki, Y. Pathology of human malignant mesothelioma – preliminary analysis of 1,517 mesothelioma cases. Ind Health. 2001;39:183–85.
264.Suzuki, Y. Pathology of human malignant mesothelioma. Semin Oncol. 1981;8:268–82.
265.Suzuki, Y, Kannerstein, M. Ultrastructure of human malignant diffuse mesothelioma. Am J Pathol. 1976;85:241–62.
266.Burns, TR, Greenberg, SD, Mace, ML, Johnson, EH. Ultrastructural diagnosis of epithelial malignant mesothelioma. Cancer. 1985;56:2036–40.
267.Guo, G, Chmielecki, J, Goparaju, C, Heguy, A, Dolgalev, I, Carbone, M, et al. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res. 2015;75:264–69.
268.Sekido, Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 2013;34:1413–19.
269.Chung, CT, Santos, Gda C, Hwang, DM, Ludkovski, O, Pintilie, M, Squire, JA, et al. FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma. J Clin Pathol. 2010;63:630–34.
270.Farzin, M, Toon, CW, Clarkson, A, Sioson, L, Watson, N, Andrici, J, et al. Loss of expression of BAP1 predicts longer survival in mesothelioma. Pathology. 2015;47:302–07.
271.Alakus, H, Yost, SE, Woo, B, French, R, Lin, GY, Jepsen, K, et al. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma. J Transl Med. 2015;13:122.
272.Nasu, M, Emi, M, Pastorino, S, Tanji, M, Powers, A, Luk, H, et al. High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol. 2015;10:565–76.
273.Arzt, L, Quehenberger, F, Halbwedl, I, Mairinger, T, Popper, HH. BAP1 protein is a progression factor in malignant pleural mesothelioma. Pathol Oncol Res. 2014;20:145–51.
274.de Klerk, N, Alfonso, H, Olsen, N, Reid, A, Sleith, J, Palmer, L, et al. Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia. Int J Cancer. 2013;132:1423–28.
275.Bianchi, C, Bianchi, T. Pleural mesothelioma in a couple of brothers. Indian J Occup Environ Med. 2013;17:122–23.
276.Bianchi, C, Brollo, A, Ramani, L, Bianchi, T, Giarelli, L. Familial mesothelioma of the pleura – a report of 40 cases. Ind Health. 2004;42:235–39.
277.Ascoli, V, Mecucci, C, Knuutila, S. Genetic susceptibility and familial malignant mesothelioma. Lancet. 2001;357:1804.
278.Heineman, EF, Bernstein, L, Stark, AD, Spirtas, R. Mesothelioma, asbestos, and reported history of cancer in first-degree relatives. Cancer. 1996;77:549–54.
279.Bianchi, C, Brollo, A, Zuch, C. Asbestos-related familial mesothelioma. Eur J Cancer Prev. 1993;2:247–50.
280.Hammar, SP, Bockus, D, Remington, F, Freidman, S, LaZerte, G. Familial mesothelioma: a report of two families. Hum Pathol. 1989;20:107–12.
281.Lynch, HT, Katz, D, Markvicka, SE. Familial mesothelioma: review and family study. Cancer Genet Cytogenet. 1985;15:2535.
282.Li, FP, Lokich, J, Lapey, J, Neptune, WB, Wilkins, EW. Familial mesothelioma after intense asbestos exposure at home. JAMA. 1978;240:467.
283.Orenstein, MR, Schenker, MB. Environmental asbestos exposure and mesothelioma. Curr Opin Pulm Med. 2000;6:371–77.
284.Dawson, A, Gibbs, A, Browne, K, Pooley, F, Griffiths, M. Familial mesothelioma. Details of 17 cases with histopathologic findings and mineral analysis. Cancer. 1992;70:1183–87.
285.Li, FP, Dreyfus, MG, Antman, KH. Asbestos-contaminated nappies and familial mesothelioma. Lancet. 1989;1:909–10.
286.Abratt, RP, Vorobiof, DA, White, N. Asbestos and mesothelioma in South Africa. Lung Cancer. 2004;45(Suppl 1):S36.
287.Haliloglu, M, Hoffer, FA, Fletcher, BD. Malignant peritoneal mesothelioma in two pediatric patients: MR imaging findings. Pediatr Radiol. 2000;30:251–55.
288.Goyal, M, Swanson, KF, Konez, O, Patel, D, Vyas, PK. Malignant pleural mesothelioma in a 13-year-old girl. Pediatr Radiol. 2000;30:776–78.
289.Niggli, FK, Gray, TJ, Raafat, F, Stevens, MC. Spectrum of peritoneal mesothelioma in childhood: clinical and histopathologic features, including DNA cytometry. Pediatr Hematol Oncol. 1994;11:399408.
290.Kelsey, A. Mesothelioma in childhood. Pediatr Hematol Oncol. 1994;11:461–62.
291.Antman, KH, Ruxer, RL., Aisner, J, Vawter, G. Mesothelioma following Wilms’ tumor in childhood. Cancer. 1984;54:367–69.
292.Brenner, J, Sordillo, PP, Magill, GB. Malignant mesothelioma in children: report of seven cases and review of the literature. Med Pediatr Oncol. 1981;9:367–73.
293.Kumar, R, Chitkara, NL. Peritoneal malignant mesothelioma in children. Indian J Cancer. 1966;3:190–97.
294.Arora, SK, Srinivasan, R, Nijhawan, R, Bansal, D, Menon, P. Malignant biphasic peritoneal mesothelioma in a child: fine-needle aspiration cytology, histopathology, and immunohistochemical features along with review of literature. Diagn Cytopathol. 2012;40:1112–15.
295.Paterson, A, Grundy, R, de Goyet, Jde V, Raafat, F, Beath, S, McCarthy, A. Congenital malignant peritoneal mesothelioma. Pediatr Radiol. 2003;33:7374.
296.Nishioka, H, Furusho, K, Yasunaga, T, Tanaka, K, Yamanouchi, A, Yokota, T, et al. Congenital malignant mesothelioma. A case report and electron-microscopic study. Eur J Pediatr. 1988;147:428–30.
297.Hountis, P, Chounti, M, Matthaios, D, Romanidis, K, Moraitis, S. Surgical treatment for malignant pleural mesothelioma: extrapleural pneumonectomy, pleurectomy/decortication or extended pleurectomy? J BUON. 2015;20:376–80.
298.Elbahaie, AM, Kamel, DE, Lawrence, J, Davidson, NG. Late cutaneous metastases to the face from malignant pleural mesothelioma: a case report and review of the literature. World J Surg Oncol. 2009;7:84.
299.Wagner, D, Bourne, PA, Yang, Q, Goldman, BI, Lewis, JS., Xu, H. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes. Appl Immunohistochem Mol Morphol. 2008;16:301–07.
300.Muljono, A, Ng, T, McMaster, J, Dexter, M. Choroid plexus metastases from pleural sarcomatoid mesothelioma. Pathology. 2008;40:530–32.
301.Lester, T, Xu, H. Malignant pleural mesothelioma with osseous metastases and pathologic fracture of femoral neck. Appl Immunohistochem Mol Morphol. 2008;16:507–09.
302.Abdel, Rahman AR, Gaafar, RM, Baki, HA, El Hosieny, HM, Aboulkasem, F, Farahat, EG, et al. Prevalence and pattern of lymph node metastasis in malignant pleural mesothelioma. Ann Thorac Surg. 2008;86:391–95.
303.Teh, AY, Ball, D, O'Day, J, Cassumbhoy, R. Bilateral choroidal metastases from mesothelioma. J Thorac Oncol. 2006;1:712–13.
304.Cimbaluk, D, Kasuganti, D, Kluskens, L, Reddy, V, Gattuso, P. Malignant biphasic pleural mesothelioma metastatic to the liver diagnosed by fine-needle aspiration. Diagn Cytopathol. 2006;34:3336.
305.Tho, LM, O'Rourke, NP. Unusual metastases from malignant pleural mesothelioma. Clin Oncol (R Coll Radiol). 2005;17:293.
306.Patel, T, Bansal, R, Trivedi, P, Modi, L, Shah, MJ. Subcutaneous metastases of sarcomatoid mesothelioma with its differential diagnosis on fine needle aspiration – a case report. Indian J Pathol Microbiol. 2005;48:482–84.
307.Mah, E, Bittar, RG, Davis, GA. Cerebral metastases in malignant mesothelioma: case report and literature review. J Clin Neurosci. 2004;11:917–18.
308.Lumb, PD, Suvarna, SK. Metastasis in pleural mesothelioma. Immunohistochemical markers for disseminated disease. Histopathology. 2004;44:345–52.
309.Ambroggi, M, Orlandi, E, Foroni, RP, Cavanna, L. Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review. World J Surg Oncol. 2014;12:129.
310.Miller, AC, Miettinen, M, Schrump, DS, Hassan, R. Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review. Ann Am Thorac Soc. 2014;11:1075–81.
311.Purek, L, Laroumagne, S, Dutau, H, Maldonado, F, Astoul, P. Miliary mesothelioma: a new clinical and radiological presentation in mesothelioma patients with prolonged survival after trimodality therapy. J Thorac Oncol. 2011;6:1753–56.
312.Musk, AW. More cases of miliary mesothelioma. Chest. 1995;108:587.
313.Huncharek, M. Miliary mesothelioma. Chest. 1994;106:605–06.
314.Musk, AW, Dewar, J, Shilkin, KB, Whitaker, D. Miliary spread of malignant pleural mesothelioma without a clinically identifiable pleural tumour. Aust N Z J Med. 1991;21:460–62.
315.Mazurek, JM, Syamlad, G, Wood, JM, Hendricks, SA, Weston, A. Malignant mesothelioma mortality – United States, 1999–2015. MMWR Mortal Wkly Rep. 2017;66(8):214–18.
316.Taioli, E, Wolf, AS, Camacho-Rivera, M, Flores, RM. Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg. 2014;98:1020–24.
317.Richards, WG, Godleski, JJ, Yeap, BY, Corson, JM, Chirieac, LR, Zellos, L, et al. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer. 2010;116:1510–17.
318.Miura, JT, Johnston, FM, Gamblin, TC, Turaga, KK. Current trends in the management of malignant peritoneal mesothelioma. Ann Surg Oncol. 2014;21:3947–53.
319.Magge, D, Zenati, MS, Austin, F, Mavanur, A, Sathaiah, M, Ramalingam, L, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014;21:1159–65.
320.Shih, CA, Ho, SP, Tsy, FW, Lai, KH, Hsu, PI. Diffuse malignant peritoneal mesothelioma. Kaohsiung J Med Sci. 2013;29:642–45.
321.Chua, TC, Chong, CH, Morris, DL. Peritoneal mesothelioma: current status and future directions. Surg Oncol Clin N Am. 2012;21:635–43.
322.Hassan, R, Alexander, R, Antman, K, Boffetta, P, Churg, A, Coit, D, et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006;17:1615–19.
323.Andrici, J, Jung, J, Sheen, A, D'Urso, L, Sioson, L, Pickett, J, et al. Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma. Hum Pathol. 2016;51:915.
324.Judge, S, Thomas, P, Govindarajan, V, Sharma, P, Loggie, B. Malignant peritoneal mesothelioma: characterization of the inflammatory response in the tumor microenvironment. Ann Surg Oncol. 2016;23:1496–500.
325.Hubert, J, Thiboutot, E, Dube, P, Cloutier, AS, Drolet, P, Sideris, L. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal mesothelioma: preliminary results and survival analysis. Surg Oncol. 2015;24:4146.
326.Pillai, K, Pourgholami, MH, Chua, TC, Morris, DL. Oestrogen receptors are prognostic factors in malignant peritoneal mesothelioma. J Cancer Res Clin Oncol. 2013;139:987–94.
327.Hsu, LN, Sung, MT, Chiang, PH. Paratesticular malignant mesothelioma in a patient exposed to asbestos for more than 50 years. Kaohsiung J Med Sci. 2014;30:537–38.
328.Manganiello, M, Cassalman, C, Dugan, J, Bennett, N. Scrotal mesothelioma. Can J Urol. 2014;21:7163–65.
329.Busto, Martin L, Portela, Pereira P, Sacristan, Lista F, Busto, Castanon L. Mesothelioma of the tunica vaginalis. Case report. Arch Esp Urol. 2013;66:384–88.
330.Shelton, D, Dalal, N. Mesothelioma of the tunica vaginalis with BerEp4 and LeuM1 expression: identification of cytoplasmic tonofilaments by electron microscopy is a key diagnostic feature. J Clin Pathol. 2012;65:958–59.
331.Priester, P, Kopecky, J, Prosvicova, J, Petera, J, Zoul, Z, Slovacek, L. Cutaneous recurrence of malignant mesothelioma of the tunica vaginalis testis: a rare case report. Onkologie. 2012;35:4648.
332.Belli, E, Landolfo, K. Primary pericardial mesothelioma: a rare cause of constrictive pericarditis. Asian Cardiovasc Thorac Ann. 2015;23:599600.
333.Gong, W, Ye, X, Shi, K, Zhao, Q. Primary malignant pericardial mesothelioma – a rare cause of superior vena cava thrombosis and constrictive pericarditis. J Thorac Dis. 2014;6:E272–75.
334.Oc, M, Oc, B, Dogan, R. Unexpected malignant pericardial mesothelioma presenting as pericardial constriction. Bratisl Lek Listy. 2012;113:620–21.
335.Feng, X, Zhao, L, Han, G, Khalil, M, Green, F, Ogilvie, T, et al. A case report of an extremely rare and aggressive tumor: primary malignant pericardial mesothelioma. Rare Tumors. 2012;4:e21.
336.Kamiya, M, Eimoto, T. Malignant mesothelioma of the tunica vaginalis. Pathol Res Pract. 1990;186:680–84; discussion 685–86.
337.Sardar, MR, Kuntz, C, Patel, T, Saeed, W, Gnall, E, Imaizumi, S, et al. Primary pericardial mesothelioma unique case and literature review. Tex Heart Inst J. 2012;39:261–64.
338.Choi, WS, Im, MS, Kang, JH, Kim, YG, Hwang, IC, Lee, JM, et al. Primary malignant pericardial mesothelioma presenting as acute pericarditis. J Cardiovasc Ultrasound. 2012;20:5759.
339.Tsuruya, K, Matsushima, M, Nakajima, T, Fujisawa, M, Shirakura, K, Igarashi, M, et al. Malignant peritoneal mesothelioma presenting umbilical hernia and Sister Mary Joseph's nodule. World J Gastrointest Endosc. 2013;5:407–11.
340.Chakravartty, S, Singh, JC, Jayamanne, H, Shah, V, Williams, GL, Stephenson, BM. Peritoneal mesothelioma masquerading as an inguinal hernia. Ann R Coll Surg Engl. 2012;94:e111–12.
341.Chakravartty, S, Singh, JC, Jayamanne, H, Shah, V, Williams, GL, Stephenson, BM. Peritoneal mesothelioma masquerading as an inguinal hernia. Ann R Coll Surg Engl. 2011;93:e107–08.
342.Stradella, A, Conde-Gallego, E, Escalera-Almendros, CA, Duran-Martinez, I. Malignant mesothelioma of tunica vaginalis. Actas Urol Esp. 2014;38:6869.
343.Lee, S, Illei, PB, Han, JS, Epstein, JI. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases. Am J Surg Pathol. 2014;38:5459.
344.Henderson, DW, Reid, G, Kao, SC, van Zandwijk, N, Klebe, S. Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. J Clin Pathol. 2013;66:847–53.
345.Mangano, WE, Cagle, PT, Churg, A, Vollmer, RT, Roggli, VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol. 1998;110:191–99.
346.Henderson, DW, Shilkin, KB, Whitaker, D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review. Am J Clin Pathol. 1998;110:397404.
347.Cagle, PT, Churg, A. Differential diagnosis of benign and malignant mesothelial proliferations on pleural biopsies. Arch Pathol Lab Med. 2005;129:1421–27.
348.Shen, J, Pinkus, GS, Deshpande, V, Cibas, ES. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol. 2009;131:516–23.
349.Husain, AN, Mirza, MK, Gibbs, A, Hiroshima, K, Chi, Y, Boumendjel, R, et al. How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study. Lung Cancer. 2014;83:324–28.
350.Kato, Y, Tsuta, K, Seki, K, Maeshima, AM, Watanabe, S, Suzuki, K, et al. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 2007;20:215–20.
351.Hayes, JP, Wiggins, J, Ward, K, Muldowney, F, FitzGerald, MX. Familial cryptogenic fibrosing pleuritis with Fanconi's syndrome (renal tubular acidosis). A new syndrome. Chest. 1995;107:576–78.
352.Baris, YI, Sahin, AA, Ozesmi, M, Kerse, I, Ozen, E, Kolacan, B, et al. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia. Thorax. 1978;33:181–92.
353.Churg, A, Cagle, P, Colby, TV, Corson, JM, Gibbs, AR, Hammar, S, et al. The fake fat phenomenon in organizing pleuritis: a source of confusion with desmoplastic malignant mesotheliomas. Am J Surg Pathol. 2011;35:1823–29.
354.Lin, XM, Chi, C, Chen, J, Liu, Y, Li, P, Yang, Y. Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature. J Cardiothorac Surg. 2013;8:50.
355.Pritchard, SA, Howat, AJ, Edwards, JM. Immunohistochemical panel for distinction between squamous cell carcinoma, adenocarcinoma and mesothelioma. Histopathology. 2003;43:197–99.
356.Johnson, JS, Edwards, JM. Malignant mesothelioma mimicking squamous carcinoma in a pleural fluid aspirate. Cytopathology. 2001;12:5456.
357.Ordonez, NG. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215–21.
358.Pelosi, G, Fabbri, A, Tamborini, E, Perrone, F, Testi, AM, Settanni, G, et al. Challenging lung carcinoma with coexistent DeltaNp63/p40 and thyroid transcription factor-1 labeling within the same individual tumor cells. J Thorac Oncol. 2015;10:1500–02.
359.Agackiran, Y, Ozcan, A, Akyurek, N, Memis, L, Findik, G, Kaya, S. Desmoglein-3 and napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes. Appl Immunohistochem Mol Morphol. 2012;20:350–55.
360.Kao, SC, Griggs, K, Lee, K, Armstrong, N, Clarke, S, Vardy, J, et al. Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology. 2011;43:313–17.
361.Kannerstein, M, Churg, J, McCaughey, WT, Hill, DP. Papillary tumors of the peritoneum in women: mesothelioma or papillary carcinoma. Am J Obstet Gynecol. 1977;127:306–14.
362.Shukuya, T, Serizawa, M, Watanabe, M, Akamatsu, H, Abe, M, Imai, H, et al. Identification of actionable mutations in malignant pleural mesothelioma. Lung Cancer. 2014;86:3540.
363.Kawai, T, Hiroi, S, Nakanishi, K, Takagawa, K, Haba, R, Hayashi, K, et al. Lymphohistiocytoid mesothelioma of the pleura. Pathol Int. 2010;60:566–74.
364.Galateau-Sallé, F, Attanoos, R, Gibbs, AR, Burke, L, Astoul, P, Rolland, P, et al. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases. Am J Surg Pathol. 2007;31:711–16.
365.Yao, DX, Shia, J, Erlandson, RA, Klimstra, DS. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review. Ultrastruct Pathol. 2004;28:213–28.
366.Khalidi, HS, Medeiros, LJ, Battifora, H. Lymphohistiocytoid mesothelioma. An often misdiagnosed variant of sarcomatoid malignant mesothelioma. Am J Clin Pathol. 2000;113:649–54.
367.Henderson, DW, Attwood, HD, Constance, TJ, Shilkin, KB, Steele, RH. Lymphohistiocytoid mesothelioma: a rare lymphomatoid variant of predominantly sarcomatoid mesothelioma. Ultrastruct Pathol. 1988;12:367–84.
368.Clevenger, J, Joseph, C, Dawlett, M, Guo, M, Gong, Y. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears. Cancer Cytopathol. 2014;122:779–85.
369.Granter, SR, Weilbaecher, KN, Quigley, C, Fisher, DE. Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma. Appl Immunohistochem Mol Morphol. 2002;10:4751.
370.Muramatsu, Y, Isobe, K, Sugino, K, Kinoshita, A, Wada, T, Sakamoto, S, et al. Malignant pleural mesothelioma mimicking the intrapulmonary growth pattern of epithelioid hemangioendothelioma. Pathol Int. 2014;64:358–60.
371.Bahrami, A, Allen, TC, Cagle, PT. Pulmonary epithelioid hemangioendothelioma mimicking mesothelioma. Pathol Int. 2008;58:730–34.
372.Nind, NR, Attanoos, RL, Gibbs, AR. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma. Histopathology. 2003;42:150–55.
373.Attanoos, RL, Dallimore, NS, Gibbs, AR. Primary epithelioid haemangioendothelioma of the peritoneum: an unusual mimic of diffuse malignant mesothelioma. Histopathology. 1997;30:375–77.
374.Lin, BT, Colby, T, Gown, AM, Hammar, SP, Mertens, RB, Churg, A, et al. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol. 1996;20:1431–39.
375.Sullivan, HC, Edgar, MA, Cohen, C, Kovach, CK, HooKim, K, Reid, MD. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. J Clin Pathol. 2015;68:4450.
376.Fan, C, Liu, Y, Lin, X, Han, Y, He, A, Wang, E. Epithelioid angiosarcoma at chest wall which needs to be carefully distinguished from malignant mesothelioma: report of a rare case. Int J Clin Exp Pathol. 2014;7:9056–60.
377.Klabatsa, A, Nicholson, AG, Dulay, K, Rudd, RM, Sheaff, MT. Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components – a hitherto undescribed pattern of differentiation. Histopathology. 2012;60:1164–66.
378.Kao, YC, Chow, JM, Wang, KM, Fang, CL, Chu, JS, Chen, CL. Primary pleural angiosarcoma as a mimicker of mesothelioma: a case report. Diagn Pathol. 2011;6:130.
379.Ordonez, NG. D2–40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol. 2005;36:372–80.
380.Liu, B, Liu, L, Li, Y. Giant solitary fibrous tumor of the pleura: a case report. Thorac Cancer. 2015;6:368–71.
381.Kamata, T, Sakurai, H, Nakagawa, K, Watanabe, SI, Tsuta, K, Asamura, H. Solitary fibrous tumor of the pleura: morphogenesis and progression. A report of 36 cases. Surg Today. 2016;46(3):335–40.
382.Creytens, D, Libbrecht, L, Ferdinande, L. Nuclear expression of STAT6 in dedifferentiated liposarcomas with a solitary fibrous tumor-like morphology: a diagnostic pitfall. Appl Immunohistochem Mol Morphol. 2015;23:462–63.
383.Benabdejlil, Y, Kouach, J, Babahabib, A, Elhassani, ME, Rharassi, I, Boudhas, A, et al. Intraperitoneal solitary fibrous tumor. Case Rep Obstet Gynecol. 2014;2014:906510.
384.Teo, A, Hemmings, C, Miller, R. Sarcomatoid localised mesothelioma mimicking intrapulmonary synovial sarcoma: a case report and review of the literature. Pathology. 2010;42:182–84.
385.Cappello, F, Barnes, L. Synovial sarcoma and malignant mesothelioma of the pleura: review, differential diagnosis and possible role of apoptosis. Pathology. 2001;33:142–48.
386.Weinbreck, N, Vignaud, JM, Begueret, H, Burke, L, Benhattar, J, Guillou, L, et al. SYT–SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura. Mod Pathol. 2007;20:617–21.
387.Somasundaram, S, Khajanchi, M, Vaja, T, Jajoo, B, Dey, AK. Benign multicystic peritoneal mesothelioma: a rare tumour of the abdomen. Case Rep Surg. 2015;2015:613148.
388.Marien, T, Zhou, M, Brucker, B. Benign multicystic mesothelioma masquerading as a urachal cyst. Can J Urol. 2014;21:7586–88.
389.Campbell, B, Mehanna, D, Stone, J. Benign multicystic peritoneal mesothelioma: a rare cause of intra-abdominal cystic disease. ANZ J Surg 2017;87(6):e1516.
390.Witek, TD, Marchese, JW, Farrell, TJ. A recurrence of benign multicystic peritoneal mesothelioma treated through laparoscopic excision: a case report and review of the literature. Surg Laparosc Endosc Percutan Tech. 2014;24:e7073.
391.Momeni, M, Pereira, E, Grigoryan, G, Zakashansky, K. Multicystic benign cystic mesothelioma presenting as a pelvic mass. Case Rep Obstet Gynecol. 2014;2014:852583.
392.Mino, JS, Monteiro, R, Pigalarga, R, Varghese, S, Guisto, L, Rezac, C. Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature. BMJ Case Rep. 2014;2014:bcr2013200212.
393.Wang, TB, Dai, WG, Liu, DW, Shi, HP, Dong, WG. Diagnosis and treatment of benign multicystic peritoneal mesothelioma. World J Gastroenterol. 2013;19:6689–92.
394.Tamhankar, VA. Multicystic benign mesothelioma complicating pregnancy. Case Rep Obstet Gynecol. 2015;2015:687183.
395.Oks, M, He, T, Palkar, A, Esposito, MJ, Koenig, SJ. Benign multicystic mesothelioma causing bilateral pneumothoraces. Ann Am Thorac Soc. 2015;12:1106–09.
396.Agarwal, S, Mullick, S, Gupta, K, Prasad, S. Pleural multicystic mesothelial proliferation: a mimicker of benign peritoneal mesothelioma. Indian J Pathol Microbiol. 2013;56:476–77.
397.Singh, A, Chatterjee, P, Pai, MC, Chacko, RT. Multicystic peritoneal mesothelioma: not always a benign disease. Singapore Med J. 2013;54:e7678.
398.McCaughey, WT, Colby, TV, Battifora, H, Churg, A, Corson, JM, Greenberg, SD, et al. Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel. Mod Pathol. 1991;4:342–53.
399.Galateau-Sallé, F, Vignaud, JM, Burke, L, Gibbs, A, Brambilla, E, Attanoos, R, et al. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol. 2004;28:534–40.
400.McCaughey, WT, Al-Jabi, M, Kannerstein, M. A Canadian experience of the pathological diagnosis of diffuse mesothelioma. IARC Sci Publ. 1980;207–10.
401.Andrion, A, Magnani, C, Betta, PG, Donna, A, Mollo, F, Scelsi, M, et al. Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol. 1995;48:856–60.
402.Skov, BG, Lauritzen, AF, Hirsch, FR, Skov, T, Nielsen, HW. Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies. Histopathology. 1994;25:431–37.
403.Val-Bernal, JF, Mayorga, M, Val, D, Garijo, MF. Well-differentiated papillary mesothelioma manifesting in a hernia sac. Pathol Res Pract. 2014;210:609–12.
404.Nasit, JG, Dhruva, G. Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology. Am J Clin Pathol. 2014;142:233–42.
405.Irwin, GW, Ervine, A, Kennedy, JA. Well-differentiated papillary mesothelioma: peritoneal implants are not always metastases in the presence of cancer. Scott Med J. 2014;59:e1821.
406.Erdogan, S, Acikalin, A, Zeren, H, Gonlusen, G, Zorludemir, S, Izol, V. Well-differentiated papillary mesothelioma of the tunica vaginalis: a case study and review of the literature. Korean J Pathol. 2014;48:225–28.
407.Costanzo, L, Scarlata, S, Perrone, G, Rossi, L, Papa, A, Di Matteo, FM, et al. Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report. Clin Respir J. 2014;8:124–29.
408.Washimi, K, Yokose, T, Amitani, Y, Nakamura, M, Osanai, S, Noda, H, et al. Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report. Pathol Int. 2013;63:220–25.
409.Daya, D, McCaughey, WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer. 1990;65:292–96.
410.Burrig, KF, Pfitzer, P, Hort, W. Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol. 1990;417:443–47.
411.Malpica, A, Sant'Ambrogio, S, Deavers, MT, Silva, EG. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012;36:117–27.
412.Hoekstra, AV, Riben, MW, Frumovitz, M, Liu, J, Ramirez, PT. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005;98:161–67.
413.Churg, A, Allen, T, Borczuk, AC, Cagle, PT, Galateau-Sallé, F, Hwang, H, et al. Well-differentiated papillary mesothelioma with invasive foci. Am J Surg Pathol. 2014;38:990–98.
414.Trpkov, K, Barr, R, Kulaga, A, Yilmaz, A. Mesothelioma of tunica vaginalis of “uncertain malignant potential” – an evolving concept: case report and review of the literature. Diagn Pathol. 2011;6:78.
415.Zardawi, SJ, Li, BT, Zauderer, MG, Wang, JW, Atmore, BB, Barnes, TA, et al. Localized malignant pleural mesothelioma with renal metastasis. Oxf Med Case Reports. 2015;2015:170–72.
416.Giansanti, M, Bellezza, G, Guerriero, A, Pireddu, A, Sidoni, A. Localized intrasplenic mesothelioma: a case report. Int J Surg Pathol. 2013;22:451–55.
417.Gelvez-Zapata, SM, Gaffney, D, Scarci, M, Coonar, AS. What is the survival after surgery for localized malignant pleural mesothelioma? Interact Cardiovasc Thorac Surg. 2013;16:533–37.
418.Andrews, W, Paul, S, Narula, N, Altorki, NK. Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer. Interact Cardiovasc Thorac Surg. 2013;17:1061–62.
419.Nakano, T, Hamanaka, R, Oiwa, K, Nakazato, K, Masuda, R, Iwazaki, M. Localized malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg. 2012;60:468–74.
420.Morimoto, D, Fujimoto, N, Nishi, H, Asano, M, Fuchimoto, Y, Ono, K, et al. Malignant pleural mesothelioma localized in the thoracic wall. J Thorac Oncol. 2012;7:e2122.
421.Kim, Y, Lee, E, Jung, W, Kim, HK, Jung, SH, Hong, KD, et al. Localized malignant peritoneal mesothelioma arising in the mesentery of the ascending colon. Am Surg. 2012;78:E255–57.
422.Papalambros, A, Sigala, F, Vouza, EG, Hepp, W, Antonakis, P. Sister Mary Joseph's nodule as primary localized malignant mesothelioma. Report of a case. Zentralbl Chir. 2011;136:172–74.
423.Ouazzani, A, Rondelet, B, Sokolow, Y, Ruiz, Patino M, Remmelink, M, Cappello, M. Localized malignant lymphohistiocytoid pleural mesothelioma. Acta Chir Belg. 2011;111:3843.
424.Hayashi, H, Notohara, K, Yoshioka, H, Matsuoka, T, Ikeda, H, Kagawa, K, et al. Localized malignant pleural mesothelioma showing a thoracic mass and metastasizing to the stomach. Intern Med. 2010;49:671–75.
425.Tanzi, S, Tiseo, M, Internullo, E, Cacciani, G, Capra, R, Carbognani, P, et al. Localized malignant pleural mesothelioma: report of two cases. J Thorac Oncol. 2009;4:1038–40.
426.Akamoto, S, Ono, Y, Ota, K, Suzaki, N, Sasaki, A, Matsuo, Y, et al. Localized malignant mesothelioma in the middle mediastinum: report of a case. Surg Today. 2008;38:635–38.
427.Takahashi, H, Harada, M, Maehara, S, Kato, H. Localized malignant mesothelioma of the pleura. Ann Thorac Cardiovasc Surg. 2007;13:262–66.
428.Allen, TC, Cagle, PT, Churg, AM, Colby, TV, Gibbs, AR, Hammar, SP, et al. Localized malignant mesothelioma. Am J Surg Pathol. 2005;29:866–73.
429.Robinson, LA, Reilly, RB. Localized pleural mesothelioma. The clinical spectrum. Chest. 1994;106:1611–15.
430.You, Q, Zhao, J, Shi, G, Deng, J, Teng, X. Epithelioid malignant mesothelioma presenting with features of gastric tumor in a child. Int J Clin Exp Pathol. 2014;7:2636–40.
431.Kuroda, K, Ishizawa, S, Kudo, T, Uotani, H, Hosokawa, A, Tanaka, T, et al. Localized malignant mesenteric mesothelioma causing small bowel obstruction. Pathol Int. 2008;58:239–43.
432.Al-Qahtani, M, Morris, B, Dawood, S, Onerheim, R. Malignant mesothelioma of the tunica vaginalis. Can J Urol. 2007;14:3514–17.
433.Erdogan, E, Demirkazik, FB, Gulsun, M, Ariyurek, M, Emri, S, Sak, SD. Incidental localized (solitary) mediastinal malignant mesothelioma. Br J Radiol. 2005;78:858–61.
434.Hirano, H, Takeda, S, Sawabata, Y, Okumura, Y, Maeda, H, Hanibuchi, M, et al. Localized pleural malignant mesothelioma. Pathol Int. 2003;53:616–21.